France
· Delayed Price · Currency is EUR Facephi Biometria Statistics
Total Valuation
EPA:ALPHI has a market cap or net worth of EUR 60.88 million. The enterprise value is 67.19 million.
| Market Cap | 60.88M |
| Enterprise Value | 67.19M |
Important Dates
The last earnings date was Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 25.58M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +19.32% |
| Shares Change (QoQ) | +24.96% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 23.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 202.92 |
| PS Ratio | 1.82 |
| PB Ratio | 3.17 |
| P/TBV Ratio | 8.23 |
| P/FCF Ratio | 127.34 |
| P/OCF Ratio | 84.03 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.56 |
| EV / Sales | 2.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 140.54 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.64.
| Current Ratio | 1.08 |
| Quick Ratio | 1.08 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | n/a |
| Debt / FCF | 25.58 |
| Interest Coverage | -3.96 |
Financial Efficiency
Return on equity (ROE) is -45.19% and return on invested capital (ROIC) is -11.69%.
| Return on Equity (ROE) | -45.19% |
| Return on Assets (ROA) | -7.90% |
| Return on Invested Capital (ROIC) | -11.69% |
| Return on Capital Employed (ROCE) | -26.57% |
| Revenue Per Employee | 143,605 |
| Profits Per Employee | -38,130 |
| Employee Count | 233 |
| Asset Turnover | 0.70 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.50% in the last 52 weeks. The beta is 1.07, so EPA:ALPHI's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +19.50% |
| 50-Day Moving Average | 2.38 |
| 200-Day Moving Average | 1.94 |
| Relative Strength Index (RSI) | 48.44 |
| Average Volume (20 Days) | 319 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EPA:ALPHI had revenue of EUR 33.46 million and -8.88 million in losses. Loss per share was -0.35.
| Revenue | 33.46M |
| Gross Profit | 28.62M |
| Operating Income | -6.03M |
| Pretax Income | -7.33M |
| Net Income | -8.88M |
| EBITDA | -5.48M |
| EBIT | -6.03M |
| Loss Per Share | -0.35 |
Balance Sheet
The company has 5.91 million in cash and 12.23 million in debt, giving a net cash position of -6.31 million.
| Cash & Cash Equivalents | 5.91M |
| Total Debt | 12.23M |
| Net Cash | -6.31M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 19.19M |
| Book Value Per Share | 0.76 |
| Working Capital | 2.05M |
Cash Flow
In the last 12 months, operating cash flow was 724,430 and capital expenditures -246,362, giving a free cash flow of 478,068.
| Operating Cash Flow | 724,430 |
| Capital Expenditures | -246,362 |
| Free Cash Flow | 478,068 |
| FCF Per Share | n/a |
Margins
Gross margin is 85.55%, with operating and profit margins of -18.01% and -26.55%.
| Gross Margin | 85.55% |
| Operating Margin | -18.01% |
| Pretax Margin | -21.91% |
| Profit Margin | -26.55% |
| EBITDA Margin | -16.38% |
| EBIT Margin | -18.01% |
| FCF Margin | 1.43% |
Dividends & Yields
EPA:ALPHI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.32% |
| Shareholder Yield | n/a |
| Earnings Yield | -14.59% |
| FCF Yield | 0.79% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EPA:ALPHI has an Altman Z-Score of 0.88. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.88 |
| Piotroski F-Score | n/a |